2018 – New Code201820192020202120222023Billable/Specific Code
- D47.09 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM D47.09 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D47.09 – other international versions of ICD-10 D47.09 may differ.
ICD-10-CM D47.09 is grouped within Diagnostic Related Group(s):
- 820 Lymphoma and leukemia with major o. R. Procedures with mcc
- 821 Lymphoma and leukemia with major o. R. Procedures with cc
- 822 Lymphoma and leukemia with major o. R. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
Applicable To
- Extracutaneous mastocytoma
- Mast cell tumor NOS
- Mastocytoma NOS
- Mastocytosis NOS
Code History
- 2018 (effective 10/1/2017): New code
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D47.09:
- of uncertain behavior NEC > neoplasm C96.20
- tumor > Mast cell
- mast cell, of uncertain behavior NEC > Neoplasm, neoplastic
- mast cell > Tumor
